Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
MGI Tech Co., Ltd. (MGI) is a global company committed to building core tools and technology to lead life science. MGI focuses on the R&D, manufacturing, and sales of DNA sequencing instruments, reagents, and related products. Their cutting-edge technologies empower a wide range of applications in research, clinical diagnostics, agriculture, and beyond, aiming to make high-quality, affordable genomic information accessible to all.
Serves as the central command for MGI's global operations, including core research and development, strategic planning, manufacturing oversight, and corporate functions.
Features advanced R&D laboratories for genomics and life sciences, state-of-the-art manufacturing facilities for sequencing instruments and reagents, and modern office spaces designed for collaboration.
Characterized by a strong emphasis on scientific innovation, rapid development cycles, and a collaborative environment. Employees are often highly skilled in biotechnology, engineering, and data science. The culture supports continuous learning and addressing complex biological challenges.
Serves as the core of MGI's global R&D and manufacturing network. Its location in Shenzhen, a global technology hub, provides access to a rich talent pool, advanced supply chains, and a supportive ecosystem for high-tech enterprises, crucial for MGI's mission to develop leading-edge life science tools.
MGI has established a significant global footprint with operations, R&D centers, manufacturing facilities, and customer support networks spanning Asia-Pacific, Europe, the Americas, Africa and the Middle East. This allows MGI to serve a worldwide customer base in academic research, clinical diagnostics, pharmaceuticals, and applied markets, providing localized support and access to its advanced gene sequencing technologies.
Main Office Buildings 2&11, Beishan Industrial Zone, Yantian District
Shenzhen
Guangdong
China
Address: 2901 Tasman Dr, Ste 112, Santa Clara, CA 95054, USA
To drive adoption of MGI's sequencing platforms and solutions in the Americas, supporting clinical and research institutions.
Address: Rankas street 10, Riga, LV-1005, Latvia
To ensure efficient supply chain and manufacturing capabilities for the European market, facilitate regional R&D, and provide localized customer support.
Address: 20 Ayer Rajah Crescent, #06-01, Singapore 139964
To expand MGI's footprint in the diverse and growing APAC life sciences market, fostering collaborations and providing tailored solutions.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, MGI Worldwide' leadership includes:
MGI Worldwide has been backed by several prominent investors over the years, including:
MGI has been strategically strengthening its regional leadership teams, particularly in key growth markets like the Americas, with notable appointments aimed at enhancing its clinical and medical affairs capabilities and driving market expansion.
Discover the tools MGI Worldwide uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
MGI commonly uses email formats such as [firstinitial][last]@mgi-tech.com or [first].[last]@mgi-tech.com. Variations might exist based on department or region.
[firstinitial][last]@mgi-tech.com
Format
jdoe@mgi-tech.com
Example
75%
Success rate
BioSpectrum Asia • April 24, 2024
MGI Tech Co. Ltd. announced a strategic collaboration with AITbiotech Pte. Ltd., a Singapore-based genomics and biotechnology company, to enhance genomic sequencing capabilities and promote precision medicine across Southeast Asia....more
Business Wire • February 7, 2024
MGI showcased its DNBSEQ-G99 sequencer at the AGBT 2024 General Meeting, highlighting its ultra-fast speed and flexibility for various genomic applications such as WGS, WES, RNA-Seq, and targeted sequencing....more
PR Newswire • January 9, 2024
MGI announced the launch of DNBSEQ-T20×2CL, a clinical version of its ultra-high throughput sequencer, aiming to accelerate the adoption of genomic sequencing in clinical diagnostics and personalized medicine....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including MGI Worldwide, are just a search away.